BAC
Bank of America Corporation
BAC has a slight edge over THG overall, supported by stronger modeled upside and stronger fundamentals.
THG
The Hanover Insurance Group, Inc.
THG offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
THG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
THG's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like THG.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
THG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $219 | -12% |
| Current | 12x | $248 | — |
| Fair | 13x | $273 | +9.9% |
| Forward | 13x | $248 | — |
| Expensive | 17x | $360 | +45% |
Historical ranges are pointers, not guarantees.
THG has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over THG on the outlook, with more favorable valuation and revenue expectations.
THG Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect THG's earnings to grow and its profitability to improve, with its revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
THG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $19.65 | -6% |
| Q3 2026 | $20.90 | +21% |
| Q2 2026 | $20.94 | +38% |
| Q1 2026 | $19.86 | +65% |
| Q4 2025 | $18.16 | +55% |
| Q3 2025 | $17.30 | +71% |
| Q2 2025 | $15.20 | +101% |
| Q1 2025 | $12.02 | +167% |
| Q4 2024 | $11.70 | +1094% |
THG has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over THG on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over THG on profitability, with a higher operating margin.
THG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +4.2% |
| Q2 2026 | $1.7B | +4.3% |
| Q1 2026 | $1.7B | +6.1% |
| Q4 2025 | $1.7B | +5.5% |
| Q3 2025 | $1.7B | +6.4% |
| Q2 2025 | $1.7B | +7.7% |
| Q1 2025 | $1.6B | +3.4% |
| Q4 2024 | $1.6B | +3.6% |
THG's revenue has grown year over year for 17 quarters in a row: $1.7B last quarter, up 4.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | -0.8 points |
| Q2 2026 | 15% | +1.9 points |
| Q1 2026 | 15% | +3.1 points |
| Q4 2025 | 17% | +1.2 points |
| Q3 2025 | 15% | +5.3 points |
| Q2 2025 | 13% | +6.5 points |
| Q1 2025 | 12% | +2 points |
| Q4 2024 | 16% | +5.7 points |
THG's operating margin was 14% last quarter, down 0.8 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
THG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $518M | -6.1% |
| Q2 2026 | $209.4M | +2.2% |
| Q1 2026 | $115.3M | +211% |
| Q4 2025 | $377M | +79% |
| Q3 2025 | $551.4M | +41% |
| Q2 2025 | $204.9M | +49% |
| Q1 2025 | $37.1M | -34% |
| Q4 2024 | $210.5M | +133% |
THG has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over THG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
THG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -100K shares |
| 1 year | -2.5% | -900K shares |
| 3 years | -1.7% | -600K shares |
| 5 years | -2.2% | -800K shares |
| Available history | -13% | -5.1M shares |
THG has 36M diluted shares, down 2.5% from a year ago, with $283M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $86.4M |
| Q2 2026 | $55M |
| Q1 2026 | $86.9M |
| Q4 2025 | $54.6M |
| Q3 2025 | $36M |
| Q2 2025 | $27.6M |
| Q1 2025 | $11M |
| Q3 2023 | — |
THG spent $283M buying back its own shares over the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
THG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.3x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | 0.5x | Very low |
THG has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
THG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.1 | Overbought |
| Stochastic | 82.0 | Overbought |
THG's weekly RSI is 73 (overbought) and its Stochastic is 82 (overbought).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
THG PE vs Financial Services Sector
| Metric | THG | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 8.8% below |
| PE % | 36 | 63 | 27 pts below |
THG has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
THG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $232.5 | 6.7% above |
| 20 week MA | $227.3 | 9.1% above |
| 50 week MA | $200.1 | 24% above |
| 100 week MA | $184.1 | 35% above |
| 200 week MA | $156.4 | 59% above |
THG has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
THG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $136.4 | $116.1 | -15% |
| 2021 | $116.1 | $127.7 | +10% |
| 2022 | $127.7 | $137.4 | +7.6% |
| 2023 | $137.4 | $121.4 | -12% |
| 2024 | $121.4 | $154.3 | +27% |
| 2025 | $154.3 | $184.2 | +19% |
| 2026 YTD | $184.2 | $248.0 | +35% |
THG has the edge over BAC on returns for 2026, with the stronger performance.